🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
601,32 USD
Máx. histórico
601,32
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
430,02 – 609,99
Variación hoy
+0,87%
Cierre anterior
596,13
Rango de hoy
596,14 – 606,16
Volumen hoy
595.233
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,54 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 17 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 13/11/2002 | 7,93 | 8,03 | 7,88 | 7,93 | +0,06% | 1,95% | 89.200 |
| 12/11/2002 | 7,67 | 8,07 | 7,67 | 7,92 | +3,19% | 5,22% | 389.800 |
| 11/11/2002 | 7,90 | 7,95 | 7,51 | 7,68 | -2,97% | 5,57% | 376.600 |
| 08/11/2002 | 7,93 | 7,98 | 7,66 | 7,91 | -0,50% | 3,97% | 349.200 |
| 07/11/2002 | 7,90 | 8,05 | 7,75 | 7,95 | +0,00% | 3,73% | 368.000 |
| 06/11/2002 | 7,95 | 8,04 | 7,82 | 7,95 | +0,57% | 2,77% | 249.200 |
| 05/11/2002 | 7,82 | 7,95 | 7,68 | 7,91 | +1,35% | 3,52% | 176.800 |
| 04/11/2002 | 7,53 | 7,83 | 7,53 | 7,80 | +4,00% | 3,99% | 591.400 |
| 01/11/2002 | 7,51 | 7,55 | 7,43 | 7,50 | +0,33% | 1,60% | 300.200 |
| 31/10/2002 | 7,53 | 7,75 | 7,41 | 7,48 | -0,33% | 4,52% | 240.200 |
| 30/10/2002 | 7,57 | 7,58 | 7,45 | 7,50 | -0,66% | 1,65% | 243.800 |
| 29/10/2002 | 7,75 | 7,75 | 7,24 | 7,55 | +1,34% | 6,58% | 225.400 |
| 28/10/2002 | 7,17 | 7,63 | 7,17 | 7,45 | +2,41% | 6,49% | 308.800 |
| 25/10/2002 | 7,20 | 7,30 | 7,15 | 7,28 | +2,03% | 2,08% | 187.200 |
| 24/10/2002 | 7,10 | 7,20 | 6,98 | 7,13 | +0,71% | 3,10% | 469.200 |
| 23/10/2002 | 7,16 | 7,25 | 7,02 | 7,08 | -1,94% | 3,21% | 216.800 |
| 22/10/2002 | 7,51 | 7,60 | 7,14 | 7,22 | -5,25% | 6,13% | 284.000 |
| 21/10/2002 | 7,55 | 7,70 | 7,31 | 7,62 | +1,53% | 5,17% | 153.600 |
| 18/10/2002 | 7,62 | 7,63 | 7,40 | 7,51 | -0,92% | 2,95% | 210.600 |
| 17/10/2002 | 7,71 | 7,71 | 7,44 | 7,58 | +0,33% | 3,44% | 126.600 |
| 16/10/2002 | 7,48 | 7,75 | 7,35 | 7,55 | -0,72% | 5,35% | 229.600 |
| 15/10/2002 | 7,38 | 7,74 | 7,37 | 7,61 | +1,06% | 5,02% | 406.000 |
| 14/10/2002 | 7,22 | 7,53 | 7,10 | 7,53 | +5,99% | 5,96% | 237.000 |
| 11/10/2002 | 7,05 | 7,28 | 6,93 | 7,10 | +1,50% | 5,04% | 234.400 |
| 10/10/2002 | 7,36 | 7,37 | 6,96 | 7,00 | -5,15% | 5,57% | 343.400 |
| 09/10/2002 | 7,95 | 7,95 | 7,31 | 7,38 | -6,65% | 8,06% | 398.400 |
| 08/10/2002 | 7,93 | 8,01 | 7,78 | 7,90 | +0,00% | 2,90% | 340.600 |
| 07/10/2002 | 8,05 | 8,25 | 7,80 | 7,90 | -2,11% | 5,53% | 192.200 |
| 04/10/2002 | 8,11 | 8,25 | 7,87 | 8,07 | -0,74% | 4,75% | 160.400 |
| 03/10/2002 | 8,01 | 8,22 | 7,91 | 8,13 | -0,25% | 3,87% | 161.200 |